CEREBYX vs DEPACON

Independent side-by-side comparison.

Rated against independent regulatory sources·Last updated August 20, 2026·How we rate

Possible drug interaction. CEREBYX and DEPACON are different prescription medicines. Combining or switching between them can cause interactions — talk to a pharmacist or prescriber before making changes. This page is not medical advice.

Attribute	CEREBYX	DEPACON
Rating	New	72/100
Pharmacy pays	—	—
Type	RX	RX
Active ingredient	FOSPHENYTOIN SODIUM	VALPROATE SODIUM
Manufacturer	Parke Davis	Abbvie
Dosage forms	Injectable	Injectable
Drug class	Anti-Epileptic Agent	Anti-Epileptic Agent
Boxed warning	Boxed warning	None
Half-life	—	about 9 to 16 hours (the label's mean terminal, or elimination, half-life for valproate monotherapy after oral doses of 250 to 1,000 mg)
Treats	Seizures, Status Epilepticus	—

cerebyx depacon

Rating

New

72/100

Pharmacy pays

—

Type

Active ingredient

FOSPHENYTOIN SODIUM

VALPROATE SODIUM

Manufacturer

Parke Davis

Abbvie

Dosage forms

Injectable

Drug class

Anti-Epileptic Agent

Boxed warning

None

Half-life

—

about 9 to 16 hours (the label's mean terminal, or elimination, half-life for valproate monotherapy after oral doses of 250 to 1,000 mg)

Treats

Seizures, Status Epilepticus

—

Frequently asked questions

What is the difference between Cerebyx and Depacon?

Cerebyx contains Fosphenytoin Sodium, while Depacon contains Valproate Sodium — they have different active ingredients.

Ratings are based on FDA regulatory (recall-safety) data. This comparison is for general reference only — not medical advice. Always consult a licensed professional before choosing or switching a medication.